Results 181 to 190 of about 233,381 (331)
P5765Prevalence, predictors, and clinical outcome of left ventricular reverse remodeling after catheter ablation for atrial fibrillation in patients with reduced ejection fraction [PDF]
Masato Okada +13 more
openalex +1 more source
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu +22 more
wiley +1 more source
Digoxin-induced ventricular fibrillation in undiagnosed Wolff-Parkinson-White syndrome: a clinical reminder - a letter to the editor. [PDF]
Shahzad K +4 more
europepmc +1 more source
Ventricular fibrillation as a primary manifestation of Wolff-Parkinson-White syndrome [PDF]
Tereza Eichlerová +2 more
openalex +1 more source
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti +23 more
wiley +1 more source
Predicting acute decompensated heart failure using circadian markers from heart rate time series
Circadian metrics—amplitude, mesor, and acrophase—derived from a wrist‐worn heart rate monitor can predict acute decompensated heart failure (ADHF) up to 21 days before onset. In 65 post‐ADHF patients, an LSTM model achieved 74% sensitivity, and 73% specificity trained on 21‐day sequences. These findings support circadian rhythm analysis as a promising
Valerie A. A. van Es +9 more
wiley +1 more source
Refractory Ventricular Fibrillation Successfully Managed with Thrombolysis and Prolonged Resuscitation: A Case Report. [PDF]
Aslam ZR, Ghoniem A.
europepmc +1 more source
Abstract Aims The EMAIL‐HF trial aims to evaluate whether a digital guideline implementation strategy can increase and accelerate initiation of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and results EMAIL‐HF is a pragmatic, registry‐based, randomized controlled trial including patients with a ...
Mariam Elmegaard +21 more
wiley +1 more source

